by neville@docmode.com | Dec 1, 2023 | Blog, Cardiovascular Disease, Heart Failure
Dr. Mriganka Baruah Medicine Specialist &; Diabetologist, MBBS, MD (Medicine) Rehed. No13898 (AMC), Fellowship in Diabetes (CMC, Vellore), Fellowship in Diabetes (Diabetes india). The study aimed to assess the effectiveness of sacubitril/valsartan in...
by neville@docmode.com | Dec 1, 2023 | Blog, Heart Failure
Dr. Priyank Bhatt M.S., M.Ch, Director, Department of Cardiovascular and Thoracic Surgery, SAL Hospital, Gujarat The study aimed to compare the impact of sacubitril/valsartan on life-threatening arrhythmias, atrial fibrillation, echocardiography...
by neville@docmode.com | Dec 1, 2023 | Blog, Cardiovascular Disease, Heart Failure
Dr. Vishalkumar Vanani MBBS, MD, Medicine, DNB Cardiology (Jaslok Hospital,Mumbai), Dr. Vishal Heart Care, Comprehensive Cardiovascular Clinic. This study evaluated the efficacy and safety of angiotensin receptor-neprilysin inhibitor sacubitril-valsartan...
by neville@docmode.com | Dec 1, 2023 | Blog, Heart Failure
Dr. Sanjay Waghani MBBS, MD, DM (Cardiology) Interventional Cardiologist A study involving 50 patients with heart failure and impaired systemic right ventricle systolic function found that sacubitril / valsartan reduces hospitalization rates and...
by neville@docmode.com | Dec 1, 2023 | Blog, Heart Failure
Dr. Sharad Jain MD, DM, Sr. Consultant Interventional Cardiologist Appollo Hospitals International Ltd. Based on the study results, Sacubitril/Valsartan therapy significantly reduced the risk of hospitalization for heart failure and the incidence of renal...
